Skip to main content

Table 1 %GE, GC, serum cytokine levels (pg/ml) and colonic cytokine levels (pg/g colon) in mice that underwent splenectomy or sham surgery, followed by the CLP procedure and administration of vehicle or 8 mg/kg GTS-21

From: Effects of splenectomy and GTS-21, a selective α7 nicotinic acetylcholine receptor agonist, on the development of septic ileus in mice

GI transit study (n= 11)

%GE

GC

Nonseptic animals

88.96 ± 8.13

4.86 ± 0.45

Sham + vehicle + CLP

53.27 ± 10.32

2.53 ± 0.42

Sham + GTS-21 8 mg/kg + CLP

83.62 ± 5.91*

4.26 ± 0.35*

SPLX + vehicle + CLP

79.49 ± 8.98*

3.86 ± 0.44*

SPLX + GTS-21 8 mg/kg + CLP

77.64 ± 11.81*

3.55 ± 0.52

Cytokine level in serum ( n = 8 to 11)

IL-6

TNFα

Nonseptic animals

2.57 ± 0.48

4.95 ± 0.29

Sham + vehicle + CLP

243.56 ± 54.89

63.72 ± 21.25

Sham + GTS-21 8 mg/kg + CLP

90.26 ± 31.31*

54.23 ± 25.14

SPLX + vehicle + CLP

74.31 ± 17.45*

11.52 ± 1.99#

SPLX + GTS-21 8 mg/kg + CLP

64.98 ± 7.15*

12.81 ± 3.91#

Cytokine levels in colonic tissue ( n = 5 to 11)

IL-6

TNFα

Nonseptic animals

20.43 ± 4.87

41.30 ± 4.47

Sham + vehicle + CLP

1281.85 ± 932.10

137.15 ± 61.36

Sham + GTS-21 8 mg/kg + CLP

134.88 ± 36.15

46.46 ± 5.03*

SPLX + vehicle + CLP

214.22 ± 75.88

29.97 ± 8.60*

SPLX + GTS-21 8 mg/kg + CLP

487.49 ± 343.87

46.03 ± 17.22*

  1. Data presented as mean ± SEM. Two-way ANOVA or one-way ANOVA as appropriate with SNK post hoc testing; *P ≤ 0.05 versus sham + vehicle, #P ≤ 0.05 significant effect of splenectomy (SPLX).